116 related articles for article (PubMed ID: 32096839)
1. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.
Lopes RD; de Barros E Silva PGM; Damiani LP; Santos RHN; Alexander JH; Granger CB; Berwanger O
JAMA; 2020 Feb; 323(8):787-789. PubMed ID: 32096839
[No Abstract] [Full Text] [Related]
2. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
[TBL] [Abstract][Full Text] [Related]
3. Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials.
Ma M; Bu L; Shi L; Guo R; Yang B; Cao H; Luo L; Lu L
Drug Des Devel Ther; 2019; 13():1233-1240. PubMed ID: 31354240
[TBL] [Abstract][Full Text] [Related]
4. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
[TBL] [Abstract][Full Text] [Related]
6. High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.
Fu N; Liang M; Yang S
Angiology; 2018 Sep; 69(8):692-699. PubMed ID: 29343076
[TBL] [Abstract][Full Text] [Related]
7. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
[No Abstract] [Full Text] [Related]
8. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
9. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
[TBL] [Abstract][Full Text] [Related]
11. The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention.
Liu Q; Wang Y; Cheng X
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):215-219. PubMed ID: 30222665
[TBL] [Abstract][Full Text] [Related]
12. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
Shehata M; Fayez G; Nassar A
Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
[TBL] [Abstract][Full Text] [Related]
13. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
Tentzeris I; Rohla M; Jarai R; Farhan S; Freynhofer MK; Unger G; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K
Am J Cardiol; 2014 Apr; 113(7):1099-104. PubMed ID: 24462073
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate inclusion of multiple studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome.
Turgeon RD; Althouse AD
Eur Heart J; 2019 Mar; 40(11):941-942. PubMed ID: 30783662
[No Abstract] [Full Text] [Related]
15. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of multiple inappropriate studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome: editor's response.
Lüscher TF; Davies A
Eur Heart J; 2019 Mar; 40(11):943. PubMed ID: 30783647
[No Abstract] [Full Text] [Related]
17. The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.
Ma H; Liu Y; Xie H; Zhang G; Zhan H; Liu Z; Wang P; Geng Q; Guo L
Medicine (Baltimore); 2017 Aug; 96(32):e7351. PubMed ID: 28796030
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
[TBL] [Abstract][Full Text] [Related]
19. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of high intensity atorvastatin versus moderate intensity atorvastatin for acute coronary syndrome patients with diabetes mellitus.
Liu Z; Xu Y; Hao H; Yin C; Xu J; Li J; Wang Y; Xu D
Int J Cardiol; 2016 Nov; 222():22-26. PubMed ID: 27448700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
